The Use of Recombinant Human Granulocyte‐Macrophage Colony Stimulating Factor in Autologous Bone Marrow Transplantation

No abstract is available for this paper.

• Publication year

  1991

• Venue

  American Journal of Clinical Oncology

• Publication date

  1991-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000421-199112001-00004PMID 2048559
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation.

  1990cited by this paper
• GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.

  1989cited by this paper
• Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation.

  1989cited by this paper
• GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

  1989cited by this paper
• Autologous bone marrow transplantation. Current status and future directions.

  1989cited by this paper
• Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.

  1989cited by this paper
• Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.

  1988cited by this paper
• Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.

  1988cited by this paper
• The effect of recombinant GM-CSF on the recovery of monkeys transplanted with autologous bone marrow.

  1987cited by this paper
• Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non‐Hodgkin's lymphoma

  1985cited by this paper
• Granulocyte-macrophage colony-stimulating factors

  1985cited by this paper
• Treatment of resistant malignant lymphoma with cyclophosphamide, total body irradiation, and transplantation of cryopreserved autologous marrow.

  1984cited by this paper
• Marrow transplantation for acute lymphoblastic leukemia.

  1984cited by this paper

• Thiotepa‐based versus total body irradiation‐based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantati

  2016cites this paper
• T-cell depleted allogeneic hematopoietic cell transplants as a platform for adoptive therapy with leukemia selective or virus-specific T-cells

  2015cites this paper
• Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.

  2009cites this paper
• Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma

  2006cites this paper
• T-cell genetic modification for re-directed tumor recognition.

  2005cites this paper
• Strategies to enhance the therapeutic efficacy of autologous hematopoietic stem cell transplantation by posttransplantation adoptive transfer of T cells with engineered graft-versus-tumor activity.

  2005cites this paper
• T-Cell Depletion to Prevent Graft-vs-Host Disease

  2004cites this paper
• A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia

  2003cites this paper
• The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia.

  1999cites this paper
• T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.

  1998cites this paper
• Chronic myelogenous leukemia: an update on the biological findings and therapeutic approaches.

  1996cites this paper
• In vitro expansion of hematopoietic cells for clinical application.

  1995cites this paper
• Biological and clinical aspects of hematopoietic stem cells.

  1994cites this paper
• Hematological recovery after autologous bone marrow transplantation for high-grade non Hodgkin's lymphomas: a single center experience.

  1994cites this paper
• Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience.

  1993cites this paper
• Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF

  1993cites this paper
• Observations on the effects of hematopoietic colony-stimulating factors on the clinical course of bone marrow transplantation.

  1993cites this paper
• Chronic myelogenous leukemia.

  1993cites this paper
• Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.

  1993cites this paper
• Perspectives in marrow graft T-cell depletion in allogeneic matched related bone marrow transplantation.

  1992cites this paper
• Proliferation of abnormal bone marrow histiocytes, an undesired effect of granulocyte macrophage‐colony‐stimulating factor therapy in a patient with hurler's syndrome undergoing bone marrow transplantation

  1992cites this paper
• Disposition of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving high-dose chemotherapy and autologous bone marrow support.

  1992cites this paper
• Cytokines as Possible Effector Molecules in Human Cancer Therapy

  1991cites this paper
• Growth factors promote high-dose chemotherapy.

  1991cites this paper
• Cytokines and hematopoietins: physiology, pathophysiology, and potential as therapeutic agents.

  1991cites this paper